投稿ビュー
Engineering Red Blood Cells Into Drugs, Rubius Snags $25M From Flagship - Forbes
Forbes | Engineering Red Blood Cells Into Drugs, Rubius Snags $25M From Flagship Forbes Cell therapy is one of the big ideas in biotech. Entrepreneurs have become captivated by possibilities of engineering white blood cells so they can be re-infused into patients and fight cancer. One startup in the Boston area is seeking to pull off a ... |
投稿情報
10.12.2015 (3449日前)
評価
おすすめ
タグ
転職
"
"@type":
"@type":"NewsArticle"
"Auga Group"
"C" grade Nevada infrastructure
"Errol Oh"
"Jane Goodyear"
"Optimistically Cautious"
"a man and his prostate"
"akcijų pardavimas"
"analytics:simplereach:id":"54
"author":"Art Berman"
"author":"Brad McMillan"
"author":"Bryan Rich"
"author":"Christopher Helman"
"author":"Claire Poole"
"author":"Clare O'Connor"
"author":"David Blackmon"